Remedent, Inc. – ‘SB-2’ on 7/24/02 – EX-99

On:  Wednesday, 7/24/02, at 9:23am ET   ·   Accession #:  1157523-2-646   ·   File #:  333-96999

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration of Securities by a Small-Business Issuer   —   Form SB-2
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SB-2        Remedent Usa SB-2                                     38    213K 
17: EX-28       Exhibit 10.7                                           4±    22K 
11: EX-99       Exhibit 10.1                                           9±    39K 
20: EX-99       Exhibit 10.10                                          3±    21K 
21: EX-99       Exhibit 10.11                                         13±    56K 
22: EX-99       Exhibit 10.12                                          2±    13K 
23: EX-99       Exhibit 10.13                                          2±    15K 
24: EX-99       Exhibit 10.14                                          1     13K 
25: EX-99       Exhibit 10.15                                          2±    14K 
26: EX-99       Exhibit 10.16                                          7±    34K 
27: EX-99       Exhibit 10.17                                          1     12K 
28: EX-99       Exhibit 10.18                                          1     12K 
29: EX-99       Exhibit 10.19                                          1     11K 
12: EX-99       Exhibit 10.2                                          13±    56K 
30: EX-99       Exhibit 10.20                                          1     12K 
31: EX-99       Exhibit 10.21                                          7±    33K 
32: EX-99       Exhibit 10.22                                          2±    15K 
33: EX-99       Exhibit 10.23                                          1     11K 
34: EX-99       Exhibit 10.24                                          1     11K 
13: EX-99       Exhibit 10.3                                           8±    42K 
14: EX-99       Exhibit 10.4                                           3±    18K 
15: EX-99       Exhibit 10.5                                           8±    35K 
16: EX-99       Exhibit 10.6                                           1     12K 
18: EX-99       Exhibit 10.8                                           8±    40K 
19: EX-99       Exhibit 10.9                                           1     12K 
 2: EX-99       Exhibit 2.1                                           16±    71K 
35: EX-99       Exhibit 21.1                                           1      9K 
 3: EX-99       Exhibit 3.1                                            2±    15K 
 4: EX-99       Exhibit 3.2                                            2±    14K 
 5: EX-99       Exhibit 3.3                                            2±    15K 
 6: EX-99       Exhibit 3.4                                            1     13K 
 7: EX-99       Exhibit 3.5                                            1     14K 
 8: EX-99       Exhibit 3.6                                            2±    14K 
 9: EX-99       Exhibit 3.7                                            1     13K 
10: EX-99       Exhibit 3.8                                           16±    80K 

EX-99   —   Exhibit 10.24

 Exhibit 10.24

 June 30, 2002

Mr. Stephen Ross                                                                
Mr. Cole Gehrung                                                                

This letter will serve to confirm the agreement between Remedent USA, Inc.      
(the "Company") and yourselves (the "individuals").                             

(1)  Individuals  hereby agree to the receipt of 39,918  shares of the Company's
     common stock in full  repayment of the $19,959,  representing  a portion of
     the accrued salary due to individuals as of the date of this agreement,  as
denoted below.                                                        

(2)  The Company hereby agrees to file for registration on an SB-2 Registration 
Statement, the shares of common stock outlined in (1) above.          

The above-mentioned terms are agreed upon on this day, by the following:        

/s/ Stephen F. Ross       /s/ Stephen F. Ross     /s/ Cole Gehrung              
------------------------  ---------------------   --------------------------    

Stephen F. Ross           S. Ross                 C. Gehrung                    

Chief Financial Officer   Individual              Individual                    

Remedent USA, Inc.                                                              

Stephen Ross                  $14,805                            29,610 shares  
Cole Gehrung                   $5,154                             10,308 shares 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SB-2’ Filing		Date		Other Filings
Filed on:		7/24/02
		6/30/02		10-Q
				List all Filings